Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Sanofi Building New Factory in Vietnam

By Pharmaceutical Processing | April 1, 2013

Sanofi SA said Friday that it’s building a new medicine factory in Vietnam to supply drugs to that country and others in the region.

The move is part of a fast-growing trend among major international pharmaceutical companies to put factories and research centers in emerging markets that the industry increasingly is targeting for growth.

Paris-based Sanofi said it plans to spend about $75 million to build the factory in Ho Chi Minh City.

The factory will make medicines and consumer health products for sale in Vietnam and for export to other southeast Asian countries. It’s expected to be fully operational by the end of 2015.

Medicine sales growth is declining in Western countries — long the industry’s key markets — as government and private insurance plans there push for discounted prices as part of an effort to rein in health care spending. That’s because those countries are squeezed by weak economies, budget deficits and older, sicker populations needing more medical care.

Years ago, drugmakers mainly operated sales offices and distribution centers in emerging markets, countries including China, India, Russia, Turkey, Mexico and Brazil.

Now, governments and a rising middle class in such countries are increasing spending on health care, and most big drugmakers have set goals of producing 25 percent or more of their total sales from emerging markets.

Those companies have found that setting up factories and research centers that hire local workers and collaborate with local research institutions helps sway their governments to buy more medicines from Western drugmakers, rather than just favoring local drugmakers, whose products often are of inferior quality.

And because of lower labor, land and other costs in emerging markets, the big drugmakers can sell their products at much lower prices than what they charge in the West.

Sanofi, the maker of diabetes drug Lantus and injected anticlotting drug Lovenox, noted that the new Vietnam factory will join its network of 40 manufacturing plants in emerging markets.

___

Follow Linda A. Johnson on Twitter at http://twitter.com/LindaJ_onPharma

 

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE